Twelve Below
VC Fund
New York, United States
Twelve Below is a VC fund in New York focused on Software and Information Technology. Twelve Below operates as a venture capital firm.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 31%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Twelve Below invests in
Stages Twelve Below invests in
Countries Twelve Below invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Taylor Greene
|
|||
Investment Focus
Industry
- Software 8 (18%)
- Information Technology 5 (11%)
- Health Care 4 (9%)
- Artificial Intelligence 4 (9%)
- Finance 3 (7%)
Stage
- Seed 26 (58%)
- Series A 6 (13%)
- Pre-Seed 3 (7%)
- Funding Round 2 (4%)
- Venture - Series Unknown 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Taylor Greene
Partner
|
Partner | Total investments: 16 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Board
|
Board is a 24-inch tabletop gaming console that blends the tactile, face-to-face interaction of traditional board games with the immersive and dynamic elements of video games. Designed to bring people together physically around a table, it features 12 exclusive games across arcade, strategy, action, and more, each controlled by unique physicalpieces that make gameplay intuitive. Suitable for players aged 6 and up, Board supports solo, cooperative, and competitive play, making it ideal for family game nights and social gatherings, with parental controls and no mature content. It offers a fresh, social, and interactive gaming experience that encourages engagement and fun for players of all skill levels. | $20M / Series A / Jun 02, 2026 | |
Solstice Health
|
Solstice Health is an AI life sciences marketing platform that offers a clinical data retrieval platform for oncology practice. | $21M / Series A / May 28, 2026 | |
Conduit Health
|
Conduit Health provides telehealth DME access and telepsychiatry consultations, connecting patients and providers online. | $21.9M / Series A / Mar 17, 2026 | |
Coral
|
Coral is a B2B software platform that helps heat pump installers win more customers. | $8M / Seed / Mar 09, 2026 | |
Barnwell Bio
|
Barnwell Bio analyzes waste streams for insights into animal health and farm management. | $6M / Seed / Jan 26, 2026 | |
Arya Health
|
Arya helps flex workforce operators get compensation, incentives and rewards right to grow faster, more profitably and with happier workers. | $18.2M / Series A / Oct 29, 2025 | |
|
Nome Bio
|
Nome is the Operating System for Personalized Therapies™. Where traditional pharmaceutical infrastructure was built for mass-market drugs, Nome provides the coordination layer that rare disease programs require: AI-driven genomic assessment, regulatory navigation, researcher and manufacturer matching, and end-to-end program management — all in oneplatform.Nome serves as a tech-enabled service company sitting between the patient and the clinic. For a patient or family, Nome delivers a free therapy eligibility assessment in 1–2 weeks, followed by an execution-ready action plan. For clinicians and foundations, Nome functions as an intelligent scientific program manager — handling the orchestration complexity that has historically made personalized drug development inaccessible outside of elite academic medical centers.The platform is modality-agnostic, with current focus on antisense oligonucleotides and gene therapies. Nome also operates as a preclinical CRO, offering target design, toxicology studies, and pre-clinical manufacturing services for rare genetic diseases.Founded by Steven Ringel — a rare disease patient, former Sema4, GeneDx, and Tempus operator, and founder of the Kizuna Foundation (foundation to develop retinal gene therapies) — Nome emerged from stealth in October 2025 backed by Twelve Below, Refactor Capital, and Inflect Health. | $2.7M / Seed / Oct 15, 2025 | |
Indie Health
|
Indie was founded by healthcare innovators and technologists committed to revolutionizing the independent practice landscape. Its mission is to create thriving practices that deliver exceptional patient care using modern technology. | $5.5M / Venture - Series Unknown / May 27, 2025 | |
Phaselaw
|
Phaselaw is an AI-enhanced eDiscovery platform that significantly speeds up and simplifies the review and redaction of large document collections, tailored especially for legal, HR, and compliance teams managing disclosures, litigation, or regulatory inquiries. | $2.8M / Seed / Apr 21, 2025 | |
Rondah AI
|
Rondah AI builds AI receptionists tailored for dental practices, handling inbound calls, scheduling, and front office tasks with exceptional accuracy. By deeply integrating into each practice’s workflows, Rondah delivers a bespoke, high-performing voice AI that reduces overhead and boosts patient satisfaction. | $3.5M / Pre-Seed / Apr 09, 2025 | |
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Twelve Below invest in?
Twelve Below invests primarily in Software, Information Technology and Health Care startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Twelve Below?
Public channels for Twelve Below include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Twelve Below?
The team at Twelve Below includes Taylor Greene (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
